<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Springerplus</journal-id><journal-id journal-id-type="iso-abbrev">Springerplus</journal-id><journal-title-group><journal-title>SpringerPlus</journal-title></journal-title-group><issn pub-type="epub">2193-1801</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26933628</article-id><article-id pub-id-type="pmc">4760956</article-id><article-id pub-id-type="publisher-id">1769</article-id><article-id pub-id-type="doi">10.1186/s40064-016-1769-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>A modified Tessari method for producing more foam</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jie</given-names></name><address><email>xujie_bzmc@126.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yi-fei</given-names></name><address><email>672157874@163.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>An-wei</given-names></name><address><email>chenanwei0822@163.com</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tao</given-names></name><address><email>yinyuewolf@126.com</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Shao-hua</given-names></name><address><email>lshabccba@126.com</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/></contrib><aff id="Aff1"><label/>School of Stomatology, Shandong University, No. 44, Wenhuaxi-Road, Jinan, 250012 People&#x02019;s Republic of China </aff><aff id="Aff2"><label/>Department of Oral and Maxillofacial Surgery, Stomatology Hospital of Jinan, No. 101, Jingliu-Road, Jinan, 250012 People&#x02019;s Republic of China </aff><aff id="Aff3"><label/>Department of Oral and Maxillofacial Surgery and Institute of Dental Medicine, Qilu Hospital, Shandong University, No. 107, Wenhuaxi-Road, Jinan, 250012 People&#x02019;s Republic of China </aff><aff id="Aff4"><label/>Department and Institute of Dental Medicine, Qilu Hospital, Shandong University, Wenhuaxi-Road, Jinan, 250012 People&#x02019;s Republic of China </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>129</elocation-id><history><date date-type="received"><day>29</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>12</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Xu et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p>This study aimed to develop a modified Tessari method for producing more sclerosing foam in treatment of extensive venous malformations. Sclerosing foam was produced by using Tessari method and the modified Tessari method. The procedure of the later was as follows: prepared foam in a sclerosant&#x02013;air ratio of 1:4; connected three disposable 10&#x000a0;ml syringes to two medical three-way taps; drawn 4&#x000a0;ml of liquid sclerosant into one syringe and 16&#x000a0;ml averagely of air into the other two; then moved the plungers of all syringes back and forth for 20 times to produce sclerosing foam. The volume and foam half time (FHT) of foam produced by the two methods were compared. The average volume of sclerosing foam produced by Tessari method and the modified Tessari method were 9.8 and 19.7&#x000a0;ml, and assessed to have statistical difference. The FHT of foam produced by the two methods were 120 and 150&#x000a0;s, and assessed to have statistical difference. In conclusion, the modified Tessari method could produce more fresh and stable sclerosing foam.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Sclerosing foam</kwd><kwd>Tessari technique</kwd><kwd>Modified Tessari method</kwd><kwd>Sclerotherapy</kwd><kwd>Venous malformations</kwd></kwd-group><funding-group><award-group><funding-source><institution>the National Natural Science Foundation of China</institution></funding-source><award-id>81172572</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Shao-hua</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>the Key Research &#x00026; Development Project of Shandong Province</institution></funding-source><award-id>2015GGH318012</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Shao-hua</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>Basic Research of Qilu Hospital</institution></funding-source><award-id>2014QLKY</award-id><principal-award-recipient><name><surname>Xu</surname><given-names>Jie</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>During the treatment of venous malformations (VMs) using foam sclerotherapy, one of the most popular methods to produce foam was the Tessari method which used pumping cycles of liquid and air in-and-out of a double syringe system (Nastasa et al. <xref ref-type="bibr" rid="CR6">2015</xref>; Wolmann <xref ref-type="bibr" rid="CR14">2010</xref>; Tessari <xref ref-type="bibr" rid="CR9">2001</xref>, <xref ref-type="bibr" rid="CR10">2005</xref>). In clinical treatment, sclerosing foam was prepared usually by using two 10&#x000a0;ml syringes; however, no more than 10&#x000a0;ml of sclerosing foam could be produced at a time in this way. Tessari method was originally used in the treatment of varicose veins, in most cases of which 10&#x000a0;ml of fresh sclerosing foam might be sufficient (Tessari et al. <xref ref-type="bibr" rid="CR11">2001</xref>). However, this volume might be insufficient in treating some VMs, especially when the region of lesion was extensive. Sufficient fresh sclerosing foam was needed for the treatment of extensive VMs.</p><p>There were several ways to get more fresh sclerosing foam, for example, producing foam once more, using bigger syringes or more operators and devices to produce simultaneously. However, all these methods had more or less defects. Here, we reported a modified Tessari method by using three 10&#x000a0;ml syringes which could produce more fresh foam at a time; the volume and the stability of foam produced by the two methods were compared. Foam half time (FHT), the time when half of the original liquid sclerosant was reverted to liquid state, was adopted to assess the stability of the foam.</p></sec><sec id="Sec2"><title>Methods</title><p>Disposable 10&#x000a0;ml syringes, medical three-way taps and 1&#x000a0;% lauromacrogol injection (Shanxi Tianyu Pharmaceutical Co., Ltd.) were used in this study.</p><p>Procedure of Tessari method (Tessari et al. <xref ref-type="bibr" rid="CR11">2001</xref>): drawn 2&#x000a0;ml of liquid sclerosant into one 10&#x000a0;ml syringe and 8&#x000a0;ml of air into the other 10&#x000a0;ml syringe; connected both syringes to a medical three-way tap; then, moved the plungers of both syringes back and forth for 20 times to produce sclerosing foam (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Tessari method</p></caption><graphic xlink:href="40064_2016_1769_Fig1_HTML" id="MO1"/></fig></p><p>Procedure of the modified Tessari method: drawn 4&#x000a0;ml liquid sclerosant into a 10&#x000a0;ml syringe and 16&#x000a0;ml air averagely into the other two 10&#x000a0;ml syringes; then connected all syringes to two parallel medical three-way taps; then moved the plungers of all syringes back and forth for 20 times to produce sclerosing foam (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>The modified Tessari method</p></caption><graphic xlink:href="40064_2016_1769_Fig2_HTML" id="MO2"/></fig></p><p>Detection of the foam volume and the foam FHT: Once the foam was produced, it was immediately pushed into 10 and 20&#x000a0;ml scalar syringes respectively, the scalar syringes were placed vertically with the piston beneath. Macroscopic appearance of the foam was observed and volume of the foam was recorded. The foam in the syringes gradually separated into liquid and air, with the liquid sclerosant gathered at the bottom, when half volume of the liquid sclerosant was reverted, the time as FHT was recorded.</p><p>The detection above was measured respectively for 10 times by the same operator. Each foam was prepared by using new sclerosant and all experiments were performed at an ambient temperature of 25&#x000a0;&#x000b0;C. Experimental values were compared by an independent-samples t test and analysed using SPSS 19.0. A p value &#x02264;0.05 was considered significant.</p></sec><sec id="Sec3"><title>Results</title><p>Right after production, the bubbles in foam were small and homogenous, when the foam began to re-convert to a liquid and air separated mix, foam bubbles got bigger and inhomogeneous, eventually foam converted to two components: liquid and air.</p><p>The average volume of sclerosing foam produced by Tessari method and the modified Tessari method were 9.8 and 19.7&#x000a0;ml, and assessed to have statistical difference.</p><p>The FHT of foam produced by Tessari method and the modified Tessari method were 120 and 150&#x000a0;s, and assessed to have statistical difference (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Average volume and foam half time (FHT) of foam produced by Tessari method and modified Tessari method</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Tessari method</th><th align="left">The modified Tessari method</th></tr></thead><tbody><tr><td align="left">The average volume (ml)<sup>a</sup>
</td><td char="&#x000b1;" align="char">9.8&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">19.7&#x000a0;&#x000b1;&#x000a0;0.3</td></tr><tr><td align="left">The FHT (s)<sup>a</sup>
</td><td char="&#x000b1;" align="char">120&#x000a0;&#x000b1;&#x000a0;4.13</td><td char="&#x000b1;" align="char">156&#x000a0;&#x000b1;&#x000a0;6.85</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The average volume and FHT were expressed as mean values&#x000a0;&#x000b1;&#x000a0;standard deviation</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Discussion</title><p>Owing to its high efficiency, safety and economical advantages, foam sclerotherapy was widely used in treatment of vascular abnormalities (Luebke and Brunkwall <xref ref-type="bibr" rid="CR4">2008</xref>; Myers and Roberts <xref ref-type="bibr" rid="CR5">2009</xref>; Park et al. <xref ref-type="bibr" rid="CR7">2014</xref>; Van der Vleuten et al. <xref ref-type="bibr" rid="CR12">2014</xref>; Wolmann <xref ref-type="bibr" rid="CR14">2010</xref>). The high efficiency of foam sclerotherapy was closely related to the physical obstruction of blood flow and the displacing the intravascular blood, which extended extent of contaction between the sclerosants and the vessel wall (Ikponmwosa et al. <xref ref-type="bibr" rid="CR3">2010</xref>; Wolmann <xref ref-type="bibr" rid="CR14">2010</xref>; Eckmann <xref ref-type="bibr" rid="CR2">2009</xref>; Van Deurzen et al. <xref ref-type="bibr" rid="CR13">2011</xref>). Therefore, the therapeutic effects related to whether the cavity of VMs could be replete by fresh sclerosing foam; In our clinical work, sometime more than 10&#x000a0;ml fresh sclerosing foam was needed for extensive lesion, some authors found that 10&#x000a0;ml or more sclerosing foam was safety and efficacy, and no serious complications were observed (Stimpson et al. <xref ref-type="bibr" rid="CR8">2012</xref>; Chen et al. <xref ref-type="bibr" rid="CR1">2015</xref>). In our experience, the most common complications were temporal pain with injection, swelling after injection and skin ulcer in some patients.</p><p>In our experimental and clinical experience, it was inconvenient to use 20&#x000a0;ml syringes to produce foam; and other authors had reported that 10&#x000a0;ml syringes were the best choice to produce foam considering normal handling and foam stability (Wolmann <xref ref-type="bibr" rid="CR14">2010</xref>; Nastasa et al. <xref ref-type="bibr" rid="CR6">2015</xref>). Tessari method using two 10&#x000a0;ml syringes had become one of the most popular ways to produce foam. In clinical treatment, no more than 10&#x000a0;ml of foam could be produced at a time by using two 10&#x000a0;ml syringes, which might be insufficient in treating some extensive VMs.</p><p>To get more foam at a time, we might repeat the producing procedure once more or add more operators and devices. But the process of injecting foam into extensive VMs might be interrupted. During the interval between two adjacent injections, the previous foam would be washed away by the blood. Therefore, injecting sufficient foam at a time into the cavity of extensive VMs produced better therapeutic effects (Van Deurzen et al. <xref ref-type="bibr" rid="CR13">2011</xref>). Furthermore, there was another disadvantage when using the same syringe to prepare foam for the second time, it would be hard for the plunger to slide smoothly during preparation and injection. Adding more operators and devices to produce foam simultaneously meant to use more human and material resources. The modified Tessari method could produce about 20&#x000a0;ml fresh foam at a time which, in our clinical experience, would be sufficient in treating some of extensive VMs.</p><p>FHT was a key and usually used parameter of the stability of sclerosing foam. In this study, the FHT of sclerosing foam produced by the modified Tessari method was longer than that by Tessari method, showing that the sclerosing foam produced by the modified Tessari method was more stable.</p></sec><sec id="Sec5"><title>Conclusions</title><p>The modified Tessari method could produce more fresh and stable sclerosing foam at a time which was profitable in treating extensive VMs.
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>VMs</term><def><p>venous malformations</p></def></def-item><def-item><term>FHT</term><def><p>foam half time</p></def></def-item></def-list></glossary><ack><title>Authors&#x02019; contributions</title><p>All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p>This work was supported by the National Natural Science Foundation of China (No. 81172572), the Key Research and Development Project of Shandong Province (No. 2015GGH318012) and Basic Research of Qilu Hospital (2014QLKY).</p></sec><sec id="FPar2"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>AW</given-names></name><name><surname>Liu</surname><given-names>YR</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>SH</given-names></name></person-group><article-title>Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck</article-title><source>Br J Oral Maxillofac Surg</source><year>2015</year><volume>53</volume><issue>9</issue><fpage>809</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1016/j.bjoms.2015.05.024</pub-id><pub-id pub-id-type="pmid">26113044</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckmann</surname><given-names>DM</given-names></name></person-group><article-title>Polidocanol for endovenous microfoam sclerosant therapy</article-title><source>Expert Opin Investig Drugs</source><year>2009</year><volume>18</volume><fpage>1919</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1517/13543780903376163</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikponmwosa</surname><given-names>A</given-names></name><name><surname>Abbott</surname><given-names>C</given-names></name><name><surname>Graham</surname><given-names>A</given-names></name><name><surname>Homer-Vanniasinkam</surname><given-names>S</given-names></name><name><surname>Gough</surname><given-names>MJ</given-names></name></person-group><article-title>The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy</article-title><source>Eur J Vasc Endovasc Surg</source><year>2010</year><volume>39</volume><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2009.12.025</pub-id><pub-id pub-id-type="pmid">20080424</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luebke</surname><given-names>T</given-names></name><name><surname>Brunkwall</surname><given-names>J</given-names></name></person-group><article-title>Systematic review and metaanalysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis</article-title><source>J Cardiovasc Surg (Torino)</source><year>2008</year><volume>49</volume><fpage>213</fpage><lpage>233</lpage></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>KA</given-names></name><name><surname>Roberts</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of published reports of foam sclerotherapy: what do we know conclusively?</article-title><source>Phlebology</source><year>2009</year><volume>24</volume><issue>6</issue><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1258/phleb.2009.009048</pub-id><pub-id pub-id-type="pmid">19952384</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nastasa</surname><given-names>V</given-names></name><name><surname>Samaras</surname><given-names>K</given-names></name><name><surname>Ampatzidis</surname><given-names>Ch</given-names></name><name><surname>Karapantsios</surname><given-names>TD</given-names></name><name><surname>Trelles</surname><given-names>MA</given-names></name><name><surname>Moreno-Moraga</surname><given-names>J</given-names></name><name><surname>Smarandache</surname><given-names>A</given-names></name><name><surname>Pascu</surname><given-names>ML</given-names></name></person-group><article-title>Properties of polidocanol foam in view of its use in sclerotherapy</article-title><source>Int J Pharm</source><year>2015</year><volume>478</volume><fpage>588</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.11.056</pub-id><pub-id pub-id-type="pmid">25433198</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Sang Woo</given-names></name><name><surname>Yun</surname><given-names>Ik Jin</given-names></name><name><surname>Hwang</surname><given-names>Jae Joon</given-names></name><name><surname>Lee</surname><given-names>Song Am</given-names></name><name><surname>Kim</surname><given-names>Jun Seok</given-names></name><name><surname>Chee</surname><given-names>Hyun Keun</given-names></name><name><surname>Chang</surname><given-names>Il Soo</given-names></name></person-group><article-title>Fluoroscopy-guided endovenous sclerotherapy using a microcatheter prior to endovenous laser ablation: comparison between liquid and foam sclerotherapy for varicose tributaries</article-title><source>Korean J Radiol</source><year>2014</year><volume>15</volume><issue>4</issue><fpage>481</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.3348/kjr.2014.15.4.481</pub-id><pub-id pub-id-type="pmid">25053908</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stimpson</surname><given-names>P</given-names></name><name><surname>Hewitt</surname><given-names>R</given-names></name><name><surname>Barnacle</surname><given-names>A</given-names></name><name><surname>Roebuck</surname><given-names>DJ</given-names></name><name><surname>Hartley</surname><given-names>B</given-names></name></person-group><article-title>Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children</article-title><source>Int J Pediatr Otorhinolaryngol</source><year>2012</year><volume>76</volume><issue>4</issue><fpage>569</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.ijporl.2012.01.019</pub-id><pub-id pub-id-type="pmid">22341629</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessari</surname><given-names>L</given-names></name></person-group><article-title>Extemporary sclerosing foam according to personal method: experimental clinical data and catheter usage</article-title><source>Int Angiol Suppl</source><year>2001</year><volume>1</volume><fpage>54</fpage></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessari</surname><given-names>L</given-names></name></person-group><article-title>Nouvelle technique d&#x02019;obtention de la scle&#x000b4;ro-mousse</article-title><source>Phl&#x000e9;bologie</source><year>2005</year><volume>53</volume><fpage>129</fpage></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessari</surname><given-names>L</given-names></name><name><surname>Cavezzi</surname><given-names>A</given-names></name><name><surname>Frullini</surname><given-names>A</given-names></name></person-group><article-title>Preliminary experience with a new sclerosing foam in the treatment of varicose veins</article-title><source>Dermatol Surg</source><year>2001</year><volume>27</volume><fpage>58</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11231246</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Vleuten</surname><given-names>CJ</given-names></name><name><surname>Kater</surname><given-names>A</given-names></name><name><surname>Wijnen</surname><given-names>MH</given-names></name><name><surname>Schultze Kool</surname><given-names>LJ</given-names></name><name><surname>Rovers</surname><given-names>MM</given-names></name></person-group><article-title>Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review</article-title><source>Cardiovasc Intervent Radiol</source><year>2014</year><volume>37</volume><fpage>977</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">24196269</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Deurzen</surname><given-names>B</given-names></name><name><surname>Ceulen</surname><given-names>RP</given-names></name><name><surname>Tellings</surname><given-names>SS</given-names></name><name><surname>van der Geld</surname><given-names>C</given-names></name><name><surname>Nijsten</surname><given-names>T</given-names></name></person-group><article-title>Polidocanol concentration and time affect the properties of foam used for sclerotherapy</article-title><source>Dermatol Surg</source><year>2011</year><volume>37</volume><fpage>1448</fpage><lpage>1455</lpage><pub-id pub-id-type="doi">10.1111/j.1524-4725.2011.02095.x</pub-id><pub-id pub-id-type="pmid">21790848</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolmann</surname><given-names>JC</given-names></name></person-group><article-title>Sclerosant foams Stabilities, physical properties and rheological behavior</article-title><source>Phlebologie</source><year>2010</year><volume>39</volume><fpage>208</fpage><lpage>217</lpage></element-citation></ref></ref-list></back></article>